DaVita (DVA) | Stock Overview & Key Data
DaVita Performance Comparison
Stock Range
Today's Range
Low: $127.88
High: $131.13
on October 6, 2025
52 Week Range
Low: $126.07
High: $179.60
on August 6, 2025
on January 31, 2025
All-Time High: $179.60 on January 27, 2025
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$9.4B
EPS
10.15
P/E Ratio (TTM)
12.92
Forward P/E
11.64
P/B Ratio
6.41
PEG Ratio
5.51
Div. Yield
N/A
ROE
57.94%
Beta
1.124
Debt to Equity
825.19
Financial Highlights
Profitability
Gross Margin
33.08%
Operating Margin
15.70%
Profit Margin
6.35%
Returns and Earnings
Return on Assets (TTM)
7.15%
Return on Equity (TTM)
57.94%
EBITDA
$2.6B
Net Income (TTM)
$836.3M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$163.42
Quarterly Revenue Growth (YoY)
6.10%
Quarterly Earnings Growth (YoY)
-10.50%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| DaVita DVA | 9.39B Mid-cap | 0.28% | -3.54% | -8.00% | -14.68% | -12.45% | -18.38% | 50.46% | 49.28% |
| HCA Healthcare HCA | 100.93B Large-cap | 2.50% | 5.38% | 14.06% | 23.03% | 44.26% | 9.00% | 114.28% | 220.65% |
| Tenet Healthcare THC | 17.99B Large-cap | 0.50% | 8.61% | 18.37% | 52.79% | 62.11% | 29.65% | 277.46% | 613.03% |
| Chemed CHE | 6.78B Mid-cap | -4.05% | -3.51% | -6.27% | -28.38% | -16.00% | -23.74% | 1.69% | -7.41% |
| Option Care Health OPCH | 4.51B Mid-cap | 0.73% | -4.94% | -11.75% | -21.29% | 21.15% | -5.66% | -15.07% | 100.15% |
| Amedisys AMED | 3.32B Mid-cap | 0.05% | 3.57% | 7.76% | 9.12% | 11.10% | 2.68% | -14.45% | -58.43% |
Ownership & Short Interest
Insider Ownership
49.98%
Institutional Ownership
51.88%
Shares Short
8M
Short Ratio
10.82
Short % of Shares Outstanding
21.31%
Average 10-Day Volume
638K
Average 90-Day Volume
791K
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is DVA's 52-week high and low?
- In the last 52 weeks, DaVita reached a high of $179.60 (on January 31, 2025) and a low of $126.07 (on August 6, 2025).
- What is the market cap and P/E ratio for DVA?
- Curious about DaVita's size and valuation? Its market capitalization stands at 9.39B. When it comes to valuation, the P/E ratio (trailing twelve months) is 12.92, and the forward P/E (looking ahead) is 11.64.
- Does DVA pay dividends? If so, what's the yield?
- As for dividends, DaVita isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are DaVita's main competitors or similar companies to consider before investing?
When looking at DaVita, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return HCA Healthcare
HCA100.93B Healthcare Medical Care Facilities 9.00% 114.28% Tenet Healthcare
THC17.99B Healthcare Medical Care Facilities 29.65% 277.46% Chemed
CHE6.78B Healthcare Medical Care Facilities -23.74% 1.69% Option Care Health
OPCH4.51B Healthcare Medical Care Facilities -5.66% -15.07% Amedisys
AMED3.32B Healthcare Medical Care Facilities 2.68% -14.45% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for DaVita Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of DaVita's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 57.94%, the Debt to Equity ratio from the most recent quarter is 825.19, and its Gross Profit Margin stands at 33.08%.
- What is the recent revenue and earnings growth for DVA?
- Looking at DaVita's growth, its revenue over the trailing twelve months (TTM) was $13B. Compared to the same quarter last year (YoY), quarterly revenue grew by 6.10%, and quarterly earnings saw a YoY growth of -10.50%.
- How much of DVA stock is held by insiders and institutions?
- Wondering who owns DaVita stock? Company insiders (like executives and directors) hold about 49.98% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 51.88%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.